BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Kogenix Licenses Gene Therapy for Prevention of Age-Related Dementia and Alzheimer’s

  Boston-based Kogenix licensed the patent-pending technology used in the research.

  October 31, 2017

   · 

  2 min read
• Business

  Novelion Therapeutics Expands Leadership Team With Appointment of Jeffrey Hackman as Chief Operating Officer

  Jeffrey Hackman was most recently senior vice president, head of the US Internal Medicine and Oncology franchises for Shire.

  October 31, 2017

   · 

  6 min read
• Business

  Avinger to Announce Third Quarter 2017 Results on November 9, 2017

  The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.

  October 31, 2017

   · 

  1 min read
• Business

  Alder BioPharmaceuticals to Host Conference Call to Discuss Third Quarter 2017 Financial and Operating Results

  Conference call set for 5:00 p.m. EST November 7, 2017.

  October 31, 2017

   · 

  1 min read
• Drug Development

  Catalyst Pharmaceuticals Completes Enrollment in Second Phase III Trial of Firdapse in Patients With Lambert-Eaton Myasthenic Syndrome

  Top-Line results are expected in early December.

  October 31, 2017

   · 

  5 min read
• Business

  Zogenix to Release Third Quarter 2017 Financial Results and Host Conference Call and Webcast on November 7

  The company will host a corporate update conference call and webcast on Tuesday, November 7, 2017 at 4:30 PM ET.

  October 31, 2017

   · 

  1 min read
• Business

  CymaBay Announces the Appointment of Sujal Shah as President and Chief Executive Officer

  Mr. Shah has been serving as the Interim President and Chief Executive Officer since March 2017.

  October 31, 2017

   · 

  4 min read
• Drug Development

  Geron Announces Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic Syndromes

  Janssen sponsored the application for Fast Track designation utilizing preliminary data from IMerge, the ongoing clinical trial being conducted by Janssen in lower risk MDS.

  October 31, 2017

   · 

  7 min read
• Business

  Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2017 Financial Results

  The company has focused on quality execution of our clinical studies in postpartum depression, which will inform our later stage clinical development plans for this important underserved patient population.

  October 31, 2017

   · 

  9 min read
• GN Store Nord: Transactions in Relation to Share Buyback Program - Oct. 31, 2017

  The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program.

  October 31, 2017

   · 

  2 min read